new dosing regimens for certain bisphosphonates, such as Actonel and Aclasta
June 2007
View the FDA's preliminary statement concerning bisphosphonates and atrial fibrillation
You'll hear about new dosing regimens for certain bisphosphonates, such as Actonel and Aclasta.
It's a competitive market. There is a huge number of potential patients...and big money is at stake.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote